Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001651431-20-000003
Filing Date
2020-04-24
Accepted
2020-04-24 11:30:59
Documents
1
Effectiveness Date
2020-04-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15066
  Complete submission text file 0001651431-20-000003.txt   16104
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-365710 | Film No.: 20813360